FHTX

FOGHORN THERAPEUTICS INC

FHTX·344174107·US·Common Stock·Healthcare - Biotechnology-Activist

FHTX (FOGHORN THERAPEUTICS INC) is held by 62 institutional investors as of Q2 2026. Largest holders: FMR LLC ($27.8M), BlackRock, Inc. ($12.8M), RAYMOND JAMES FINANCIAL INC ($12.2M). Net institutional sentiment: Mixed.

62
Holders
(5 Elite)
$90.1M
Total Value
60% (58)
Consensus
35 buying - 23 selling
13F: Insider & Congress: Updated regularly
FHTX

Smart Money Verdict

View all
Loading verdict
Held by 62 funds
5 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Sep 24, 2024 · Activists May 15, 2026 · Congress none

ActivistBLBVF PARTNERS L P/IL10.0%May 15, 2026
ActivistDMDeerfield Mgmt, L.P.8.6%May 14, 2026
ActivistFMR LLCFMR LLC11.6%May 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
5.7M(-5.6%)$27.8M0.0%+42.10%
0
Increased
2.6M(+11.1%)$12.8M0.0%+42.77%
31
Decreased
2.5M(-4.3%)$12.2M0.0%+45.39%
0
Decreased
1.5M(-0.0%)$7.3M0.0%+21.20%
0
Increased
910,866(+7.4%)$4.4M0.0%-37.18%
29
Increased
697,469(+2.6%)$3.4M0.0%+11.92%
27
Increased
558,685(+24.4%)$2.7M0.0%+31.25%
32
Decreased
377,936(-7.0%)$1.8M0.0%+25.66%
0
Unchanged
313,765$1.5M0.0%+21.20%
0
Increased
309,775(+12.3%)$1.5M0.0%-39.36%
29
Increased
305,434(+0.6%)$1.5M0.0%+23.45%
26
Increased
304,432(+18.9%)$1.5M0.0%+23.48%
30
Increased
264,422(+9.9%)$1.3M0.0%+22.48%
28
Increased
203,296(+150.1%)$992,0840.0%+32.77%
40
Increased
202,145(+12.1%)$986,4680.0%+23.97%
28
Increased
175,406(+52.4%)$855,9810.0%+28.11%
35
Increased
164,256(+20.7%)$801,5690.0%+33.90%
30
Decreased
158,822(-20.6%)$775,0510.0%+29.29%
0
Increased
130,346(+25.6%)$636,0880.0%+32.05%
30
Increased
109,781(+6.0%)$535,7310.0%-35.57%
26

Showing 1-20 of 70

1 / 4
FHTXFHTXFOGHORN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used